HCA Healthcare, Inc.
HCA
$395.79
$2.140.54%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 13.14% | 1.19% | -10.52% | 17.70% | 22.46% |
Total Depreciation and Amortization | 5.37% | 8.18% | 8.49% | 9.49% | 7.34% |
Total Amortization of Deferred Charges | 75.00% | 22.22% | 0.00% | 0.00% | 0.00% |
Total Other Non-Cash Items | 2,317.14% | 41.89% | 36.97% | -24.65% | -12.90% |
Change in Net Operating Assets | 420.57% | -218.30% | -86.73% | 319.33% | -152.03% |
Cash from Operations | 113.60% | -33.13% | -4.30% | 41.79% | -20.36% |
Capital Expenditure | 8.20% | 11.36% | -10.87% | -3.84% | -3.22% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -182.86% | -136.46% | 88.14% | 40.76% | -288.89% |
Divestitures | 500.00% | -48.06% | 60.00% | -90.91% | -85.71% |
Other Investing Activities | 205.88% | 2,400.00% | 62.77% | -263.16% | -21.43% |
Cash from Investing | 6.08% | -14.29% | 15.72% | -3.05% | -5.97% |
Total Debt Issued | -- | 21.64% | -100.00% | 150,500.00% | -100.00% |
Total Debt Repaid | -372.80% | 1.29% | -135.16% | -375.07% | 134.09% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -83.25% | -112.37% | -86.81% | -57.46% | -49.40% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 0.00% | 2.70% | -3.13% | -4.32% | -4.27% |
Other Financing Activities | 2.97% | 5.41% | -50.97% | -36.69% | -1.51% |
Cash from Financing | -182.62% | -22.94% | -108.18% | 90.28% | 8.76% |
Foreign Exchange rate Adjustments | 800.00% | 400.00% | -183.33% | 166.67% | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 73.29% | -350.14% | -2,270.45% | 6,993.10% | -2,365.00% |